Proteomics

Dataset Information

0

Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment


ABSTRACT: Chemotherapy treatment for breast cancer can induce cognitive impairments often involving oxidative stress. The brain, as a whole, is susceptible to oxidative stress due to its high-energy requirements, limited anaerobic respiration capacities, and limited antioxidant defenses. The goal of the current study was to determine if the manganese porphyrin SOD mimetic MnTnBuOE-2-PyP (MnBuOE) could ameliorate the effects of doxorubicin, cyclophosphamide, and paclitaxel (AC-T) on mature dendrite morphology and cognitive function. Four-month-old female C57BL/6 mice received intraperitoneal injections of chemotherapy followed by subcutaneous injections of MnBuOE. Four weeks following chemotherapy treatment, mice were tested for hippocampus-dependent cognitive performance in the Morris water maze. After testing, brains were collected for Golgi staining and molecular analyses. MnBuOE treatment preserved spatial memory during the Morris water-maze. MnBuOE/AC-T showed spatial memory retention during all probe trials. AC-T treatment significantly impaired spatial memory retention in the first and third probe trial (no platform). AC-T treatment decreased dendritic length in the Cornu Ammonis 1 (CA1) and dentate gyrus (DG) areas of the hippocampus while AC-T/MnBuOE maintained dendritic length. Comparative proteomic analysis revealed affected protein networks associated with cell morphology and behavior functions in both the AC-T and AC-T/MnBuOE treatment groups

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Stephanie Byrum  

LAB HEAD: Antino Allen

PROVIDER: PXD017271 | Pride | 2020-05-27

REPOSITORIES: Pride

altmetric image

Publications

Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment.

McElroy Taylor T   Brown Taurean T   Kiffer Fred F   Wang Jing J   Byrum Stephanie D SD   Oberley-Deegan Rebecca E RE   Allen Antiño R AR  

International journal of molecular sciences 20200309 5


<h4>Background</h4>Chemotherapy treatment for breast cancer can induce cognitive impairments often involving oxidative stress. The brain, as a whole, is susceptible to oxidative stress due to its high-energy requirements, limited anaerobic respiration capacities, and limited antioxidant defenses. The goal of the current study was to determine if the manganese porphyrin superoxide dismutase mimetic MnTnBuOE-2-PyP (MnBuOE) could ameliorate the effects of doxorubicin, cyclophosphamide, and paclitax  ...[more]

Similar Datasets

2022-02-17 | PXD028899 | Pride
2007-11-27 | E-GEOD-5078 | biostudies-arrayexpress
2006-06-20 | GSE5078 | GEO
2018-09-10 | GSE111941 | GEO
2018-09-10 | GSE111940 | GEO
2022-10-14 | PXD035933 | Pride
2018-04-20 | GSE113327 | GEO
2007-10-12 | E-GEOD-854 | biostudies-arrayexpress
2019-10-16 | PXD007574 | Pride
2007-11-29 | E-GEOD-5666 | biostudies-arrayexpress